Neuroscience, Science, Research, Brain.
compared to 25.4% of those given the placebo. This suggests that esketamine reduced the relative risk of a depressive episode by around three-quarters. Based on these results, the researchers estimate that one major depressive episode would be prevented for every five participants given esketamine.